Onconova Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Onconova Therapeutics (TRAW) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Onconova Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Onconova Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Onconova Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $24 | 55 | 0.45 |
| 2024-03-31 | $51 | 51 | 1.02 |
| 2023-12-31 | $27 | 36 | 0.75 |
| 2023-09-30 | $18 | 25 | 0.72 |
| 2022-03-31 | $9.0k | 4.8k | 1.87 |